{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:09:11Z","timestamp":1794647351326,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.critrevonc.2024.104482","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:01:07Z","timestamp":1723680067000},"page":"104482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Management of Hodgkin Lymphoma during pregnancy, review of the literature and description of an homogenous expectative attitude associated with excellent outcome."],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-0124","authenticated-orcid":false,"given":"Joshua","family":"Hag\u00e8ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorea","family":"Aguinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Moatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7213-9464","authenticated-orcid":false,"given":"Lo\u00efc","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2024.104482_bib1","unstructured":"ADCETRIS\u00ae (brentuximab vedotin), n.d."},{"key":"10.1016\/j.critrevonc.2024.104482_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bpobgyn.2015.02.006","article-title":"Management of cancer in pregnancy","volume":"29","author":"Amant","year":"2015","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol., Matern. Med."},{"key":"10.1016\/j.critrevonc.2024.104482_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","article-title":"Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study","volume":"13","author":"Amant","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000020898","article-title":"Hodgkin\u2019s Disease during Pregnancy: Diagnostic and Therapeutic Management","volume":"14","author":"Anselmo","year":"1999","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.critrevonc.2024.104482_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.143.3607.703","article-title":"Vinblastine Sulfate Treatment of Hodgkin\u2019s Disease during a Pregnancy","volume":"143","author":"Armstrong","year":"1964","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2024.104482_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","article-title":"Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children","volume":"36","author":"Avil\u00e9s","year":"1991","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clml.2015.09.009","article-title":"Speckle-tracking echocardiography to detect cardiac toxicity in children who received anthracyclines during pregnancy","volume":"16","author":"Avil\u00e8s","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.critrevonc.2024.104482_bib8","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.006","article-title":"Treatment of early stages hodgkin lymphoma during pregnancy","volume":"10","author":"Avil\u00e9s","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.critrevonc.2024.104482_bib9","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/ijc.27560","article-title":"Hematological malignancies and pregnancy: Treat or no treat during first trimester","volume":"131","author":"Avil\u00e9s","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104482_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ctrv.2009.11.004","article-title":"Treatment of the pregnant mother with cancer: A systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors","volume":"36","author":"Azim","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2024.104482_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11899-013-0163-4","article-title":"Hodgkin Lymphoma in Pregnancy","volume":"8","author":"Bachanova","year":"2013","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.critrevonc.2024.104482_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00006254-196212000-00008","article-title":"INFLUENCE OF PREGNANCY ON THE COURSE OF HODGKIN\u2019S DISEASE","volume":"17","author":"Barry","year":"1962","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.critrevonc.2024.104482_bib13","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2024.104482_bib14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007611-198408000-00032","article-title":"Acute myelogenous leukemia in pregnancy","volume":"77","author":"Cantini","year":"1984","journal-title":"South. Med. J."},{"key":"10.1016\/j.critrevonc.2024.104482_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/COC.0b013e3181a44ca9","article-title":"Perinatal Outcomes of a Pregnancy Complicated by Cancer, Including Neonatal Follow-Up After in Utero Exposure to Chemotherapy: Results of an International Registry","volume":"33","author":"Cardonick","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib17","first-page":"337","article-title":"Antineoplastic agents and pregnancy","volume":"16","author":"Dc","year":"1989","journal-title":"Semin Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2257.2006.00781.x","article-title":"Hematological malignancy and pregnancy: a single-institution experience of 21 cases","volume":"28","author":"Dilek","year":"2006","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"Randomized Comparison of ABVD and MOPP\/ABV Hybrid for the Treatment of Advanced Hodgkin\u2019s Disease: Report of an Intergroup Trial","volume":"21","author":"Duggan","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib20","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.2019000961","article-title":"How I treat lymphoma in pregnancy","volume":"136","author":"Dunleavy","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2024.104482_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<613::AID-PATH559>3.0.CO;2-0","article-title":"Expression of the CD30 antigen in non-lymphoid tissues and cells","volume":"190","author":"D\u00fcrkop","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0163-7258(97)82004-9","article-title":"Cytotoxic therapy and pregnancy","volume":"74","author":"Ebert","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2024.104482_bib23","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1515\/jpm-2014-0133","article-title":"Incidence and outcomes of women with Hodgkin\u2019s lymphoma in pregnancy: a population-based study on 7.9 million births","volume":"43","author":"El-Messidi","year":"2015","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.critrevonc.2024.104482_bib24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2024.104482_bib25","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1200\/JCO.2013.49.8220","article-title":"Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis","volume":"31","author":"Evens","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.26527","article-title":"Checkpoint inhibitor immunotherapy during pregnancy for relapsed\u2013refractory Hodgkin lymphoma","volume":"97","author":"Evens","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/bjh.13327","article-title":"Management and controversies of classical Hodgkin lymphoma in pregnancy","volume":"169","author":"Eyre","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib28","first-page":"2023010090","article-title":"An International Real-World Analysis of Relapsed\/Refractory Lymphoma Occurring During Pregnancy","author":"Farooq","year":"2023","journal-title":"Blood Adv. Bloodadvances"},{"key":"10.1016\/j.critrevonc.2024.104482_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pd.1970090913","article-title":"Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester","volume":"9","author":"Fernandez","year":"1989","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.critrevonc.2024.104482_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<304::AID-CNCR18>3.0.CO;2-#","article-title":"Pregnancy-associated lymphomas: A clinicopathologic study","volume":"78","author":"Gelb","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2024.104482_bib31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","article-title":"Anthracyclines during pregnancy: embryo\u2013fetal outcome in 160 patients","volume":"15","author":"Germann","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib32","first-page":"773","article-title":"Doxorubicin in pregnancy: possible transplacental passage","volume":"67","author":"Gi","year":"1983","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.critrevonc.2024.104482_bib33","first-page":"336","article-title":"Hodgkin\u2019s disease and pregnancy","volume":"69","author":"Gobbi","year":"1984","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2024.104482_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5625","article-title":"Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns","volume":"7","author":"Gougis","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2024.104482_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<57::AID-AJH13>3.0.CO;2-5","article-title":"Advanced Hodgkin\u2019s disease in a pregnant HIV seropositive woman: Favorable mother and baby outcome following combined anticancer and antiretroviral therapy","volume":"63","author":"Klepfish","year":"2000","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.1966.03100060126040","article-title":"Cyclophosphamide and Vinblastine Sulfate in Hodgkin\u2019s Disease During Pregnancy","volume":"195","author":"Lacher","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2024.104482_bib37","article-title":"Successful pregnancy and fetal outcome following previous treatment with pembrolizumab for relapsed Hodgkin\u2019s lymphoma","volume":"5","author":"Le-Nguyen","year":"2022","journal-title":"Cancer Rep."},{"key":"10.1016\/j.critrevonc.2024.104482_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/bjc.1992.21","article-title":"Maternal and foetal outcome following Hodgkin\u2019s disease in pregnancy","volume":"65","author":"Lishner","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104482_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100831","article-title":"Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review","volume":"49","author":"Luttwak","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.critrevonc.2024.104482_bib40","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2352-3026(19)30195-4","article-title":"Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study","volume":"6","author":"Maggen","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/ejh.12956","article-title":"The management of hodgkin lymphomas in pregnancies","volume":"99","author":"Moshe","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000421-198604000-00009","article-title":"Management of Coexisting Hodgkin\u2019s Disease and Pregnancy","volume":"9","author":"Nisce","year":"1986","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0936-6555(98)80046-0","article-title":"Hodgkin\u2019s lymphoma in a pregnant patient with acquired immunodeficiency syndrome","volume":"10","author":"Okechukwu","year":"1998","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib44","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/rheumatology\/kez405","article-title":"Oral corticosteroid use during pregnancy and risk of preterm birth","volume":"59","author":"Palmsten","year":"2020","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.critrevonc.2024.104482_bib45","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jamaoncol.2016.1396","article-title":"Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy","volume":"2","author":"Pinnix","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-61-108","article-title":"Vinblastine Sulfate in Hodgkin\u2019s Disease in Pregnancy","volume":"61","author":"Rosenzweig","year":"1964","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2024.104482_bib47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/S0002-9378(03)00537-4","article-title":"Cancer associated with obstetric delivery: results of linkage with the California cancer registry","volume":"189","author":"Smith","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/1097-0142(197609)38:3<1443::AID-CNCR2820380352>3.0.CO;2-D","article-title":"The investigation and management of Hodgkin\u2019s disease in the pregnant patient","volume":"38","author":"Thomas","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2024.104482_bib49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/1097-0142(19880201)61:3<435::AID-CNCR2820610305>3.0.CO;2-F","article-title":"Anthracyclines in the treatment of malignancy in pregnancy","volume":"61","author":"Turchi","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2024.104482_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00743-3","article-title":"Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein","volume":"408","author":"Ushigome","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.critrevonc.2024.104482_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1040-8428(94)90043-4","article-title":"Pharmacology of antineoplastic agents in pregnancy","volume":"16","author":"Wiebe","year":"1994","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:23:03Z","timestamp":1726186983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":51,"alternative-id":["S1040842824002257"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104482","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Hodgkin Lymphoma during pregnancy, review of the literature and description of an homogenous expectative attitude associated with excellent outcome.","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104482"}}